Stay updated on Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Added Primary peritoneal carcinoma and Fallopian tube cancer to the study's Conditions, and updated the page version from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-12T01:21:50.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no user-facing content changes were observed.
    Difference
    0.1%
    Check dated 2026-02-04T22:49:43.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Glossary display has been added, and a new 'Last Update Submitted that Met QC Criteria' indicator appears, along with a 'No FEAR Act Data' notice and a revision banner for v3.4.0. The previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' information has been removed.
    Difference
    0.2%
    Check dated 2026-01-28T20:29:04.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4; no changes to study details or content.
    Difference
    0.1%
    Check dated 2026-01-14T03:53:01.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    A new consolidated Locations section lists five sites (California, Georgia, Louisiana, Oklahoma, Vermont) and replaces the previous separate state location entries; the page revision is v3.3.3.
    Difference
    0.6%
    Check dated 2025-12-23T21:51:09.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    The page revision changed from v3.2.0 to v3.3.2; no study data or page functionality changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:49:07.000Z thumbnail image

Stay in the know with updates to Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rucaparib and Nivolumab Combo in Solid Tumors Clinical Trial page.